Abdulkader Rahmo

Abdulkader Rahmo, PhD, co-founder, President and Chief Scientific Officer of SMSbiotech, holds a bachelor’s degree in biochemistry from the Swiss Federal Institute of Technology (ETH) and a PhD from the University of Southern California (USC), in the field of Biochemistry. He did his postdoc at a major clinical laboratory in Munich, Germany. He became a director of the center for bio analytics in Syria (private clinical Laboratory with advanced diagnostics). In 2001, he became a member of the faculty of medicine at the University of Damascus (public university). Later he co-founded the National Commission for Biotechnology and became the head of the medical Biotechnology section (a public entity). In 2004 he became an associate professor for biochemistry and medical genetics at the international university for science and technology (private institution) and taught Molecular epidemiology at the Lebanese University Graduate school. In 2008 he became member of the high council for scientific research (the highest authority on government research in Syria). In 2013 he was visiting scientist at the Western University of Health Sciences in southern California (Private university). In 2015 he cofounded SMSbiotech inc. based on his research in stem cell biology, he is currently the CSO and president of that company. A member of the board of directors of California medical innovation institute. He has over 30 years’ experience in research and applications; he has dedicated the past eleven years to SMS cell discovery and development. Working with one of the world’s leading patent firms, he has filed nine patents related to Small Mobile Stem cell technology. The proprietary production methods include extensive knowhow and trade secrets. His main scientific interest continues to be in the field of regenerative medicine and age-related diseases.